Kurma Partners

Damae Medical develops deepLive, a non-invasive skin imaging system based on LC-OCT (Line-field Confocal Optical Coherence Tomography) that produces 3D histology-like and confocal-like images of skin tissue.

Deep TechDigital HealthMedical Devices

Anaïs Barut(Co-founder & CEO)David Siret(Co-founder & CTO)Arnaud Dubois(Co-founder & CSO)

Co-investorsParis-Saclay Seed FundIdinvest PartnersPartech Ventures

SciRhom is a biotech company developing first-in-class humanized antibodies against iRhom2, which regulates the enzyme TACE/ADAM17 to block pro-inflammatory signaling pathways.

BiotechDeep TechHealthtechMartinsried, DE

Dr. Jens Ruhe(Co-founder, Managing Director & Chief Operating Officer)Dr. Matthias Schneider(Co-founder & Chief Scientific Officer)Dr. Jan Poth(Managing Director, Chief Executive Officer)Dr. Jürgen Reeß(Chief Medical Officer)

Co-investorsAndera PartnersHadean Ventures

Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.

BiotechDeep TechMedical DevicesBerlin, DE

Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)

Co-investorsCreathor VenturesBoehringer Ingelheim Venture FundcoparionThuja Capital

Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis.

BiotechHealthtechParis, FR

Co-investorsHealthCapNovartis Venture FundRoche Venture FundYsios CapitalColumbus Venture PartnersEurazeo+1 more

Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.

BiotechHealthtechMedical Devices

Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in

Co-investorsaMoonRA CapitalBpifranceAndera PartnersAngelini VenturesPontifax Venture Capital+1 more

A digital agency that designs and builds websites and web applications, including HTML invitations with form-based response management and help desk applications.

Marketing TechSaaS

Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.

BiotechHealthtechLongevityPhiladelphia, US

Raj Kannan(Executive Officer, Director)

BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)

Co-investorsAndera PartnersAvego BioScience CapitalGlobal BioAccess FundJeito CapitalNew Rhein Healthcare Investors, LLCSeroba Life Sciences+2 more

Alveus Pharmaceuticals offers pharmaceutical development and manufacturing services, including analytical development, product formulation, quality and regulatory support, and process validation, aligned with the relevant phase of drug development.

BiotechHealthtech

AM-Pharma develops ilofotase alfa, a recombinant alkaline phosphatase enzyme therapy, and is studying it as a treatment for adults with hypophosphatasia (HPP), a rare inherited metabolic bone disease.

BiotechHealthtech

Co-investorsAndera PartnersYsios Capital

Co-investorsAndera PartnersCTI Life Sciences Fund L.P.EQT Life SciencesLSP (Life Sciences Partners)Sofinnova Partners

Argobio is a European venture builder that co-founds, invests in, and operates alongside early-stage biotech companies, turning academic scientific discoveries into VC-ready ventures with validated technology and management.

BiotechDeep TechHealthtech

Co-investorsNewfund Capital

Co-investorsM VenturesSofinnova PartnersSR One Capital Management

Co-investorsSofinnova Ventures

Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.

AI & Machine LearningBiotech

Co-investorsBioGeneration VenturesEQT Life SciencesBOMCurie CapitalV-Bio Ventures

Axithra develops a photonics-based device using Raman spectroscopy on a chip to measure the free, active fraction of drugs in patient blood for bedside therapeutic drug monitoring.

Deep TechHealthtechMedical Devices

Co-investorsQbic FundWhite Fundimec.xpandWallonie Entreprendre

BioSerenity develops and manufactures CE- and FDA-approved electrophysiological medical devices, AI, and software to capture and analyze EEG, ECG, and PSG signals for diagnosing neurological and cardiac disorders.

AI & Machine LearningDigital HealthMedical DevicesTroyes, FR

Co-investorsJolt Capital

BliNK Biomedical develops a B cell technology, based on the ISAAC and VIVA|Screen platforms, to identify and isolate specific antibody-producing cells for difficult targets from human and other species such as mouse, rabbit, and dog.

BiotechDeep TechMarseille, FR

Kiro is a CE-marked medical device application that centralizes patients' biological and medical test results, providing personalized explanations and health timelines to help people understand and track their lab results.

AI & Machine LearningDigital HealthHealthtech

Cardiologs develops software that uses clinically validated AI and cloud technology to analyze ECGs and support cardiology diagnostics.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsIsaiISAI GestionParis-Saclay Seed Fund

Charles is a French telehealth platform offering online medical consultations and personalized treatment for conditions such as sexual health, weight loss, and hair loss.

Digital HealthHealthtechWellness & Fitness

Co-investorsAccelDTCCHV CapitalInkefSalesforce Ventures

Coave Therapeutics is a biotech company developing gene therapies based on AAV vector engineering and genetic construct design, targeting neurodegenerative and ocular diseases.

BiotechHealthtechParis, FR

Co-investorsFund+Seroba Life SciencesV-Bio VenturesBpifranceInvusNovo Holdings+1 more

Corteria Pharmaceuticals develops first-in-class drugs for conditions with high unmet medical need, including worsening and acute decompensated heart failure, right heart failure, sarcopenia, and obesity with complications.

BiotechHealthtech

Co-investorsFountain Healthcare PartnersInvivo Capital PartnersJeito CapitalLifeArc VenturesOrbiMedV-Bio Ventures

DNA Script develops enzymatic DNA synthesis technology, offered through its SYNTAX platform, that lets labs produce high-quality ssDNA oligos in-house and overnight.

BiotechDeep TechHardwareParis, FR

Thomas Ybert(Founder)in

Co-investorsCoatue ManagementM Ventures

Elkedonia is developing a novel antidepressant aimed at patients who do not respond to current depression treatments, using a precision medicine approach.

BiotechDigital HealthMental Health

Co-investorsAngelini VenturesCARMA FUND

Co-investorsPontifax Venture Capital

EVL Bio is developing a selective anti-FGFR4 monoclonal antibody therapy to treat left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD).

BiotechDigital HealthLongevity

Co-investorsAdBio partners

Co-investorsCathay HealthCAP HORN VC

Germitec develops automated UV-C High-Level Disinfection devices, such as its Chronos system, for disinfecting ultrasound probes without chemicals.

HardwareHealthtechMedical Devices

Co-investorsEurazeo

Sunrise offers a 3-gram home sensor that provides overnight results to diagnose sleep apnea, connecting users with sleep specialists for personalized medical follow-up.

Digital HealthHealthtechMedical Devices

Hopia is an AI platform that automates staff scheduling for doctors and caregivers across all hospital departments, using a proprietary symbolic AI to model legal, collective, and individual rules.

AI & Machine LearningDigital HealthSaaS

Co-investorsIris Capital

ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.

BiotechHealthtech

Co-investorsAndera PartnersPfizer Venture InvestmentsPureos BioventuresAgent Capital

The page presents a biography of Dr.

Biotech

Co-investorsAvoro Capital AdvisorsEIR VenturesRA CapitalSamsara BioCapitalSunstone CapitalVivo Capital+2 more

Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.

BiotechHealthtech

Co-investorsAngelini VenturesCurie Capital

Co-investorsAndera PartnersSeroba Life SciencesVI PartnersYsios Capital

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops.

AgTechBiotechDeep Tech

Ricardo Garcia de Albain

Co-investorsGenoa VenturesSofinnova PartnersCasdin Capital

Memo Therapeutics AG is a late-stage biotech company developing therapeutic antibodies for patients with viral infections and cancer.

BiotechMedical Devices

Co-investorsAdjuvant CapitalFresenius Medical Care VenturesPureos BioventuresVerve VenturesYsios Capitalredalpine

Minoryx is a biopharmaceutical company that discovers and develops drug treatments for severe orphan diseases of the central nervous system, such as cerebral adrenoleukodystrophy and Rett syndrome.

BiotechHealthtech

Co-investorsChiesi VenturesCriteria Bio VenturesFund+Invivo Capital PartnersRoche Venture FundYsios Capital+1 more

NAOX Technologies develops in-ear EEG technology to bring brain monitoring out of the lab and into everyday life.

HardwareHealthtechMedical Devices

Nuclidium is a clinical-stage biotechnology company developing copper-based radiopharmaceuticals for cancer diagnosis and treatment, using Copper-61 for diagnostics and Copper-67 for therapeutics.

BiotechHealthtechMedical DevicesBasel, CH

Co-investorsAngelini VenturesDeepTech & Climate FondsNeva Sgr.VIVES Partners

Nuevocor is a clinical-stage biotechnology company developing genetic medicines for cardiomyopathies by targeting their underlying mechanobiology.

BiotechHealthtechSingapore, SG

Monica Shah(Chief Medical Officer)Al Gianchetti(Chief Executive Officer)

Co-investorsAngelini VenturesClavystBioBoehringer Ingelheim Venture FundHighlight CapitalSEEDS Capital

Omnidoc provides a medical collaboration platform for healthcare professionals and organizations, offering telexpertise (remote specialist advice), e-RCP (multidisciplinary team meetings), and assisted teleconsultation.

Digital HealthHealthtechSaaSParis, FR

Baptiste Truchot(Founder)in

Co-investorsNewfund CapitalAlven

PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.

BiotechDeep TechHealthtechMedical DevicesMol, BE

Sven van den berghe(CEO)Christophe Malice(CBO)Samy Bertrand(CTO)Yves Sterckx(Director of Finance & Administration)Philippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)

Co-investorsEQT Life SciencesKorysLSP (Life Sciences Partners)PMV

PathoQuest is a contract research organization offering GMP-validated next-generation sequencing (NGS) quality control assays under its iDTECT brand for viral safety testing and genetic characterization of biopharmaceuticals.

BiotechDeep TechHealthtechParis, FR

Co-investorsVerve Ventures

Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema.

BiotechHealthtech

Co-investorsBain Capital Life SciencesForesite CapitalvenBio Partners

Poppins operates a peer-to-peer rental marketplace where individuals, professionals, and local shops in the same neighborhood lend and rent everyday objects, with booking, owner messaging, and a guarantee system handled in one app.

Circular EconomyConsumerMarketplaces

Co-investorsAFI VenturesKima VenturesBNP Paribas DéveloppementEurazeoVerve Ventures

Poppins is a clinically validated digital medical device for children aged 7-11 with dyslexia and reading difficulties.

AI & Machine LearningDigital HealthEdTechHealthtechParis, FR

Co-investorsTechstarsVerve Ventures

Raidium develops an AI-native PACS viewer built on a foundation model for radiology, unifying image-viewing and diagnostic tasks in a single promptable platform.

AI & Machine LearningDigital HealthMedical Devices

Paul Herent, M.D., Msc(Founder)in

Co-investorsDebiopharm Innovation FundGalion.exeNewfund CapitalStartX

Recept AI provides an AI-powered virtual receptionist/tele-secretary service for dental practices, handling incoming calls, appointment booking, cancellations, reminders and patient record management 24/7.

AI & Machine LearningDigital HealthSaaS

Rycarma develops a novel class of therapeutics called Rycals that target ryanodine receptors (RyRs) to correct calcium channel dysfunction in serious diseases with high unmet need.

BiotechHealthtech

Co-investorsPontifax Venture Capital

Sensome develops a microchip-based tissue-sensing technology that embeds bio-impedance sensors into minimally invasive medical devices to give physicians real-time, patient-specific data during procedures.

Deep TechHealthtechMedical Devices

Co-investorsParis-Saclay Seed FundBNP Paribas DéveloppementIdinvest Partners

Shorla Oncology develops and commercializes oncology drugs for indications where existing treatments are limited, in shortage, or inadequate for the target population.

BiotechHealthtech

Co-investorsSeroba Life SciencesEnterprise Ireland

SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring.

BiotechDeep TechHealthtechMedical DevicesPortola Valley, US

MARK DAHM(Executive Officer, Director)

BoardRICHARD DEATLEY(Director)ROBERT TERRY(Director)TJ DURNAN(Director)

Step Pharma develops dencatistat (STP938), a first-in-class, orally bioavailable CTPS1 inhibitor in clinical development as a targeted oncology therapy for blood cancers such as lymphoma and essential thrombocythaemia as well as solid tumours including ovarian cancer.

BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR

Co-investorsHadean VenturesPontifax Venture CapitalSunstone CapitalV-Bio Ventures